BioMarin Pharmaceutical Inc. (BMV:BMRN)
1,077.32
-2.68 (-0.25%)
At close: Aug 20, 2025
BioMarin Pharmaceutical Market Cap
BioMarin Pharmaceutical has a market cap or net worth of 212.51 billion as of September 2, 2025. Its market cap has decreased by -33.85% in one year.
Market Cap
212.51B
Enterprise Value
197.00B
Revenue
57.77B
Ranking
n/a
PE Ratio
17.15
Stock Price
1,077.32
Market Cap Chart
Since July 23, 1999, BioMarin Pharmaceutical's market cap has increased from 4.20B to 212.51B, an increase of 4,955.28%. That is a compound annual growth rate of 16.21%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Aug 29, 2025 | 208.65B | -20.07% |
Dec 31, 2024 | 261.03B | -14.99% |
Dec 29, 2023 | 307.05B | -18.16% |
Dec 30, 2022 | 375.17B | 12.82% |
Dec 31, 2021 | 332.53B | 4.98% |
Dec 31, 2020 | 316.75B | 10.58% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Wal-Mart de México | 974.61B |
Grupo Financiero Banorte | 470.34B |
Arca Continental | 329.65B |
Industrias Peñoles | 243.93B |
GMéxico Transportes | 142.46B |
FIBRA Prologis | 111.33B |
Fibra UNO | 99.74B |
Promotora y Operadora de Infraestructura, S. A. B. de C. V. | 98.37B |